Access the full text.
Sign up today, get DeepDyve free for 14 days.
W. Waring, S. Adwani, O. Breukels, D. Webb, S. Maxwell (2004)
Hyperuricaemia does not impair cardiovascular function in healthy adultsHeart, 90
B. Ames, R. Cathcart, E. Schwiers, P. Hochstein (1981)
Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis.Proceedings of the National Academy of Sciences of the United States of America, 78 11
S. Marsoni, G. Damia (2004)
Molecular targeting: new therapeutic strategies to improve tumour apoptosis.Annals of oncology : official journal of the European Society for Medical Oncology, 15 Suppl 4
U. Khosla, Sergey Zharikov, Jennifer Finch, T. Nakagawa, Carlos Roncal, W. Mu, K. Krotova, E. Block, S. Prabhakar, Richard Johnson (2005)
Hyperuricemia induces endothelial dysfunction.Kidney international, 67 5
Is there a patho - genetic role for uric acid in
C. Berry, J. Hare (2004)
Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implicationsThe Journal of Physiology, 555
Ulf Ekelund, R. Harrison, O. Shokek, Rajiv Thakkar, R. Tunin, H. Senzaki, D. Kass, E. Marbán, J. Hare (1999)
Intravenous allopurinol decreases myocardial oxygen consumption and increases mechanical efficiency in dogs with pacing-induced heart failure.Circulation research, 85 5
F. Nieto, Carlos Iribarren, Myron Gross, George Comstock, R. Cutler (2000)
Uric acid and serum antioxidant capacity: a reaction to atherosclerosis?Atherosclerosis, 148 1
D. Muzny, Cheng Lee, C. Caskey, M. Mclean, Howard Hughes (2004)
Two independent mutational events in the loss of urate oxidase during hominoid evolutionJournal of Molecular Evolution, 34
C. Weir, S. Muir, M. Walters, K. Lees (2003)
Serum Urate as an Independent Predictor of Poor Outcome and Future Vascular Events After Acute StrokeStroke: Journal of the American Heart Association, 34
L. Niskanen, D. Laaksonen, K. Nyyssönen, G. Alfthan, H. Lakka, T. Lakka, J. Salonen (2004)
Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study.Archives of internal medicine, 164 14
Susumu Watanabe, D. Kang, Lili Feng, T. Nakagawa, J. Kanellis, H. Lan, M. Mazzali, Richard Johnson (2002)
Uric acid, hominoid evolution, and the pathogenesis of salt-sensitivity.Hypertension, 40 3
M. Alderman (2002)
Uric acid and cardiovascular risk.Current opinion in pharmacology, 2 2
M. McDermott, J. Guralnik, Monique Albay, S. Bandinelli, B. Miniati, L. Ferrucci (2004)
Impairments of Muscles and Nerves Associated with Peripheral Arterial Disease and Their Relationship with Lower Extremity Functioning: The InCHIANTI StudyJournal of the American Geriatrics Society, 52
M. Hediger, Richard Johnson, H. Miyazaki, H. Endou (2005)
Molecular physiology of urate transport.Physiology, 20
Richard Johnson, B. Rodriguez-Iturbe, D. Kang, D. Feig, J. Herrera-Acosta (2005)
A unifying pathway for essential hypertension.American journal of hypertension, 18 3
W. Doehner, N. Schoene, M. Rauchhaus, F. Leyva-Leon, D. Pavitt, D. Reaveley, G. Schuler, A. Coats, S. Anker, R. Hambrecht (2002)
Effects of Xanthine Oxidase Inhibition With Allopurinol on Endothelial Function and Peripheral Blood Flow in Hyperuricemic Patients With Chronic Heart Failure: Results From 2 Placebo-Controlled StudiesCirculation: Journal of the American Heart Association, 105
N. Ishizaka, Y. Ishizaka, E. Toda, R. Nagai, M. Yamakado (2005)
Association Between Serum Uric Acid, Metabolic Syndrome, and Carotid Atherosclerosis in Japanese IndividualsArteriosclerosis, Thrombosis, and Vascular Biology, 25
T. Pearson, G. Mensah, R. Alexander, Jeffrey Anderson, R. Cannon, M. Criqui, Y. Fadl, S. Fortmann, Yuling Hong, G. Myers, N. Rifai, Sidney Smith, K. Taubert, Russell Tracy, F. Vinicor (2003)
Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.Circulation, 107 3
Richard Johnson, D. Kang, D. Feig, S. Kivlighn, J. Kanellis, Susumu Watanabe, K. Tuttle, B. Rodriguez-Iturbe, J. Herrera-Acosta, M. Mazzali (2003)
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?Hypertension, 41 6
D. Freedman, D. Williamson, Elaine Gunter, T. Byers (1995)
Relation of serum uric acid to mortality and ischemic heart disease. The NHANES I Epidemiologic Follow-up Study.American journal of epidemiology, 141 7
A. Cherubini, Antonio Martín, C. Andrés-Lacueva, A. Iorio, M. Lamponi, P. Mecocci, B. Bartali, A. Corsi, U. Senin, L. Ferrucci (2005)
Vitamin E levels, cognitive impairment and dementia in older persons: the InCHIANTI studyNeurobiology of Aging, 26
S. Jee, S. Lee, Miyong Kim (2004)
Serum uric acid and risk of death from cancer, cardiovascular disease or all causes in menEuropean Journal of Preventive Cardiology, 11
G. Glantzounis, E. Tsimoyiannis, A. Kappas, D. Galaris (2005)
Uric acid and oxidative stress.Current pharmaceutical design, 11 32
N. Pérez, N. Pérez, W. Gao, E. Marbán (1998)
Novel myofilament Ca2+-sensitizing property of xanthine oxidase inhibitors.Circulation research, 83 4
F. Viazzi, D. Parodi, G. Leoncini, A. Parodi, V. Falqui, E. Ratto, S. Vettoretti, G. Bezante, M. Sette, G. Deferrari, R. Pontremoli (2005)
Serum Uric Acid and Target Organ Damage in Primary HypertensionHypertension, 45
P. Olexa, M. Olexová, J. Gonsorcík, I. Tkáč, Jana Kisel'ová, Mária Olejníková (1912)
Uric acid--a marker for systemic inflammatory response in patients with congestive heart failure?Wiener klinische Wochenschrift, 114 5-6
Proc Natl Acad Sci USA, 78
Y. Komaki, H. Sugiura, A. Koarai, M. Tomaki, H. Ogawa, T. Akita, T. Hattori, M. Ichinose (2005)
Cytokine-mediated xanthine oxidase upregulation in chronic obstructive pulmonary disease's airways.Pulmonary pharmacology & therapeutics, 18 4
C. Ryckman, C. Gilbert, R. Médicis, A. Lussier, Karen Vandal, P. Tessier (2004)
Monosodium urate monohydrate crystals induce the release of the proinflammatory protein S100A8/A9 from neutrophilsJournal of Leukocyte Biology, 76
J. Gimpel, J. Lahpor, A. Molen, J. Damen, J. Hitchcock (1995)
Reduction of reperfusion injury of human myocardium by allopurinol: a clinical study.Free radical biology & medicine, 19 2
T. Ukai, Cheping Cheng, H. Tachibana, A. Igawa, Zhu-shan Zhang, Heng-Jie Cheng, W. Little (2001)
Allopurinol Enhances the Contractile Response to Dobutamine and Exercise in Dogs With Pacing-Induced Heart FailureCirculation: Journal of the American Heart Association, 103
M. Carnethon, S. Fortmann, L. Palaniappan, B. Duncan, M. Schmidt, L. Chambless (2003)
Risk factors for progression to incident hyperinsulinemia: the Atherosclerosis Risk in Communities Study, 1987-1998.American journal of epidemiology, 158 11
T. Cappola, D. Kass, G. Nelson, R. Berger, G. Rosas, Z. Kobeissi, E. Marbán, J. Hare (2001)
Allopurinol Improves Myocardial Efficiency in Patients With Idiopathic Dilated CardiomyopathyCirculation: Journal of the American Heart Association, 104
H. Langford, M. Blaufox, N. Borhani, J. Curb, A. Molteni, K. Schneider, S. Pressel (1987)
Is thiazide-produced uric acid elevation harmful? Analysis of data from the Hypertension Detection and Follow-up Program.Archives of internal medicine, 147 4
Luigi Ferrucci, A. Corsi, F. Lauretani, S. Bandinelli, B. Bartali, Dennis Taub, J. Guralnik, D. Longo (2005)
The origins of age-related proinflammatory state.Blood, 105 6
R. Johnson, S. Kivlighn, Y. Kim, S. Suga, A. Fogo (1999)
Reappraisal of the pathogenesis and consequences of hyperuricemia in hypertension, cardiovascular disease, and renal disease.American journal of kidney diseases : the official journal of the National Kidney Foundation, 33 2
L. Franse, M. Pahor, M. Bari, R. Shorr, J. Wan, G. Somes, W. Applegate (2000)
Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP)Journal of Hypertension, 18
I. Kriszbacher, M. Koppán, J. Bódis (2005)
Inflammation, atherosclerosis, and coronary artery disease.The New England journal of medicine, 353 4
S. Anker, W. Doehner, M. Rauchhaus, Rakesh Sharma, D. Francis, C. Knosalla, C. Davos, M. Cicoira, W. Shamim, M. Kemp, R. Segal, K. Osterziel, F. Leyva, R. Hetzer, P. Ponikowski, A. Coats (2003)
Uric Acid and Survival in Chronic Heart Failure: Validation and Application in Metabolic, Functional, and Hemodynamic StagingCirculation: Journal of the American Heart Association, 107
M. Ochiai, A. Barretto, M. Oliveira, R. Munhoz, P. Morgado, J. Ramires (2005)
Uric acid renal excretion and renal insufficiency in decompensated severe heart failureEuropean Journal of Heart Failure, 7
L. Ferrucci, S. Bandinelli, E. Benvenuti, A. Iorio, C. Macchi, T. Harris, J. Guralnik (2000)
Subsystems Contributing to the Decline in Ability to Walk: Bridging the Gap Between Epidemiology and Geriatric Practice in the InCHIANTI StudyJournal of the American Geriatrics Society, 48
N. Nakanishi, M. Okamoto, H. Yoshida, Y. Matsuo, Kenji Suzuki, K. Tatara (2002)
Serum uric acid and risk for development of hypertension and impaired fasting glucose or Type II diabetes in Japanese male office workersEuropean Journal of Epidemiology, 18
L. Ferrucci, T. Harris, J. Guralnik, R. Tracy, M. Corti, H. Cohen, B.W.J.H. Penninx, M. Pahor, R. Wallace, R. Havlik (1999)
Serum IL‐6 Level and the Development of Disability in Older PersonsJournal of the American Geriatrics Society, 47
J. Guralnik, L. Fried, E. Simonsick, J. Kasper, M. Lafferty (1995)
The Women's Health and Aging Study: Health and Social Characteristics of Older Women with Disability
William Levine, A. Dyer, R. Shekelle, J. Schoenberger, J. Stamler (1989)
Serum uric acid and 11.5-year mortality of middle-aged women: findings of the Chicago Heart Association Detection Project in Industry.Journal of clinical epidemiology, 42 3
M. Fröhlich, A. Imhof, G. Berg, W. Hutchinson, M. Pepys, H. Boeing, R. Muche, H. Brenner, W. Koenig (2000)
Association between C-reactive protein and features of the metabolic syndrome: a population-based study.Diabetes care, 23 12
W. Guan, T. Osanai, T. Kamada, H. Hanada, H. Ishizaka, Hiroyuki Onodera, A. Iwasa, N. Fujita, S. Kudo, T. Ohkubo, K. Okumura (2003)
Effect of Allopurinol Pretreatment on Free Radical Generation after Primary Coronary Angioplasty for Acute Myocardial InfarctionJournal of Cardiovascular Pharmacology, 41
S. Salvini (1997)
A food composition database for epidemiological studies in Italy.Cancer letters, 114 1-2
G. Oyeyinka (1984)
Age and sex differences in immunocompetence.Gerontology, 30 3
R. Goldberg, C. Burchfiel, R. Benfante, David Chiu, D. Reed, K. Yano (1995)
Lifestyle and biologic factors associated with atherosclerotic disease in middle-aged men. 20-year findings from the Honolulu Heart Program.Archives of internal medicine, 155 7
J. Kanellis, Susumu Watanabe, Jin Li, D. Kang, Ping Li, T. Nakagawa, A. Wamsley, D. Sheikh-Hamad, H. Lan, Lili Feng, Richard Johnson (2003)
Uric Acid Stimulates Monocyte Chemoattractant Protein‐1 Production in Vascular Smooth Muscle Cells Via Mitogen‐Activated Protein Kinase and Cyclooxygenase‐2Hypertension, 41
Jing Fang, M. Alderman (2000)
Serum Uric Acid and Cardiovascular Mortality: The NHANES I Epidemiologic Follow-up Study, 1971-1992JAMA, 283
C. Farquharson, R. Butler, A. Hill, J. Belch, A. Struthers (2002)
Allopurinol Improves Endothelial Dysfunction in Chronic Heart FailureCirculation: Journal of the American Heart Association, 106
F. Leyva, S. Anker, I. Godsland, Mauro Teixeira, P. Hellewell, W. Kox, P. Poole‐Wilson, A. Coats (1998)
Uric acid in chronic heart failure: a marker of chronic inflammation.European heart journal, 19 12
A. Festa, S. Haffner (2005)
Inflammation and cardiovascular disease in patients with diabetes: lessons from the Diabetes Control and Complications Trial.Circulation, 111 19
B. Culleton, M. Larson, W. Kannel, Daniel Levy (1999)
Serum Uric Acid and Risk for Cardiovascular Disease and Death: The Framingham Heart StudyAnnals of Internal Medicine, 131
Yan Shi, J. Evans, K. Rock (2003)
Molecular identification of a danger signal that alerts the immune system to dying cellsNature, 425
G. Mercuro, C. Vitale, E. Cerquetani, S. Zoncu, M. Deidda, M. Fini, G. Rosano (2004)
Effect of hyperuricemia upon endothelial function in patients at increased cardiovascular risk.The American journal of cardiology, 94 7
J. Fang, M. Alderman (2000)
Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey.JAMA, 283 18
J. Wyngaarden, W. Kelley (1976)
Gout and hyperuricemia
W. Waring, A. Convery, V. Mishra, Alan Shenkin, David Webb, Simon Maxwell (2003)
Uric acid reduces exercise-induced oxidative stress in healthy adults.Clinical science, 105 4
P. Pisani, F. Faggiano, V. Krogh, D. Palli, P. Vineis, F. Berrino (1997)
Relative validity and reproducibility of a food frequency dietary questionnaire for use in the Italian EPIC centres.International journal of epidemiology, 26 Suppl 1
Aims The role of uric acid (UA) in the process of atherosclerosis and atherotrombosis is controversial. Epidemiological studies have recently shown that UA may be a risk factor for cardiovascular diseases and a negative prognostic marker for mortality in subjects with pre-existing heart failure.Methods and results We evaluate a relationship between UA levels and several inflammatory markers in 957 subjects, free of severe renal failure, from a representative Italian cohort of persons aged 6595. Plasma levels of UA and white blood cell (WBC) and neutrophil count, C-reactive protein, interleukin-1 receptor antagonist (IL-1ra), interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6r), interleukin-18 (IL-18), and tumor necrosis factor- (TNF-) were measured. Complete information on potential confounders was collected using standard methods. WBC (P0.0001), neutrophils (P<0.0001), C-reactive protein (P<0.0001), IL-1ra (P<0.0001), IL-6 (P0.0004), sIL-6r (P0.002), IL-18 (P<0.0001), TNF- (P0.0008), and the percentage of subjects with abnormally high levels of C-reactive protein (P0.004) and IL-6 (P<0.0001) were significantly higher across UA quintiles. After adjustment for age, sex, behaviour- and disease-related confounders, results were virtually unchanged. In subjects with UA within the normal range, UA was significantly and independently associated with neutrophils count, C-reactive protein, IL-6, IL-1ra, IL-18, and TNF-, whereas non-significant trends were observed for WBC (P0.1) and sIL-6r (P0.2).Conclusion A positive and significant association between UA and several inflammatory markers was found in a large population-based sample of older persons and in a sub-sample of participants with normal UA. Accordingly, the prevalence of abnormally high levels of C-reactive protein and IL-6 increased significantly across UA quintiles.
European Heart Journal – Oxford University Press
Published: May 12, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.